Qualigen Therapeutics, Inc. — Director's Dealing 2018

Sep 19, 2018

SEC Form 4/A — Form 4/A

Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2018-08-17

Reporting Person: FOEHR MATTHEW W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-17	Common Stock	P	19751	$2.04	Acquired	23251	Direct

Footnotes

F1: The previous Form 4 filed on August 20, 2018 did not reflect the Issuer's recent reverse stock split and inadvertently overstated the amount of securities beneficially owned by the Reporting Person following the reported transaction. The number included here has been updated to reflect such reverse stock split.